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Abstract
Electrical or chemical stimulation of the dorsal periaqueductal gray (DPAG) has been accepted as an animal model of panic attacks. 
This study investigates the influence of anticipatory anxiety in the occurrence of panic-like behavior induced by N-methyl-D-
aspartate (NMDA) microinjection into the DPAG of rats. Behavioral (i.e., contextual fear conditioning) and pharmacological (i.e., 
pentylenetetrazol) manipulations were employed as animal models of anticipatory anxiety. In the first experiment, animals exposed 
to contextual cues that had been previously associated with electric footshocks through contextual fear conditioning were less likely 
than non-conditioned control animals to display defensive reactions such as running and jumping in response to microinjection of 
NMDA (0.3 µl of 15.0 µg/µl) into the DPAG. In the second experiment, rats were injected intraperitoneally with the anxiogenic 
drug pentylenetetrazol (PTZ, 15 mg/kg) 5 minutes before receiving intra-DPAG microinfusion with the same dose of NMDA as in 
Experiment 1. Panic-related behaviors were registered in an experimental arena immediately after NMDA microinfusion. As compared 
with saline pre-treated animals, PTZ significantly attenuated NMDA-induced panic-like reactions. These results further demonstrate 
the usefulness of DPAG chemical stimulation as an animal model of panic attacks and suggest that behavioral and pharmacological 
activation of the brain mechanisms underlying anticipatory anxiety might exert an antipanic-like effect. Keywords: anxiety disorders, 
contextual fear conditioning, defensive behavior, N-methyl-D-aspartate, panic attack, periaqueductal gray, pentylenetetrazole.
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Introduction
Anxiety disorders constitute a heterogeneous group 
of related nosological categories. According to the DSM-
IV (1995), the diagnosis of generalized anxiety disorder 
(GAD) involves the presence of constant worry associated 
with several symptoms such as irritability, feeling tired and 
restless, and concentration difficulties. This condition can 
also lead to a variety of somatic symptoms including chronic 
diarrhea, muscle pain, headache, palpitation, tachycardia 
and gastrointestinal dysfunction. GAD is different from 
panic attacks, which are characterized by sudden surges 
of thoughts that death is imminent, or loss of control 
accompanied by major neurovegetative changes such as 
palpitations, difficulty breathing deeply, sweating, shaking, 
increased peristalsis and hypertension. Panic attacks are 
among the most prominent symptoms in panic disorder 
(PD), but they can occur in other anxiety disorders. 
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Since the noteworthy work of Klein and Fink 
(1962), which showed that imipramine had a selective 
effect in the treatment of panic attacks, the relationship 
between GAD and panic attacks has been a subject of 
intense debate. The more traditional view suggests that 
anticipatory anxiety and panic attacks are part of the 
same continuum. According to this interpretation, an 
increase in anxiety may result in a panic attack episode 
(Bouton, Mineka, & Barlow, 2001). In the same way, 
PD patients report that the majority of panic attack 
episodes occur when the patient is already at a plateau 
of extremely high anxiety (Basoglu, Marks, & Sengun, 
1992). Finally, patients who had panic attacks induced 
by sodium lactate infusion reported a high level of 
anxiety immediately before the occurrence of a panic 
attack event (Liebowitz et al. 1984).
The alternative view proposes that anxiety and 
panic attacks are qualitatively different pathologies and 
that they have a multifaceted relationship. According 
to this view, the occurrence of panic attacks can trigger 
intense anxiety reactions, but anxiety symptoms can 
inhibit the occurrence of panic attacks. Some clinical 
evidence supports this suggestion. For example, 
relaxation techniques employed during the treatment 
of anxiety symptoms can induce panic attacks (Adler, 
Craske, & Barlow, 1987). Moreover, panic attacks seem 
to occur more frequently during the initial course of PD 
when anxiety levels are relatively low, compared to later 
PD stages when the anxiety symptoms are extremely 
high (Klein & Klein, 1989). Finally, pharmacological 
results also corroborate the view that increasing anxiety 
might inhibit the occurrence of panic attacks. Patients 
diagnosed with PD and treated with serotonergic 
agonists presented a decreased occurrence of panic 
attacks (Cassano, Perugi, & McNair, 1988; Gorman et 
al. 1987), but showed an increase in anxiety symptoms 
(Targum & Marshall, 1989).
One possible explanation for these conflicting 
results is the fact that clinical expressions of different 
anxiety disorders are extremely complex (Kemp & 
Felmingham, 2008). In fact, PD is commonly associated 
with agoraphobia as well as with other anxiety or 
affective disorders (Hettema, 2008). Therefore, 
experimental research employing animal models of 
anxiety disorders is an important avenue of research to 
improve our understanding of the relationship between 
GAD and panic attacks. 
Contextual fear conditioning represents one of the 
most useful animal models of GAD (see Brandão et al., 
2008 for a review). In a typical experiment, a rat is exposed 
to a novel chamber and a brief unsignaled footshock 
is presented several minutes later. Some time later (i.e. 
next day), the animal freezes when returned to the same 
chamber in the absence of the aversive stimulus (Landeira-
Fernandez, 1996). This conditioned freezing is weakened 
by anxiety-reducing drugs (Fanselow et al., 1991) and 
enhanced by anxiety-inducing drugs (Izumi et al., 1999), 
giving it predictive value for screening pharmacological 
substances that modulate general anxiety disorder in 
humans. Pharmacological results have also indicated that 
the running response induced by chemical or electrical 
stimulation of the dorsal portion of the periaqueductal gray 
matter (DPAG) can serve as an important model of panic 
attacks (see Brandão et al., 2008 for a review). Panicolytic 
drugs such as clomipramine and fluoxetine increased 
the threshold electrical current required to elicit running 
behaviors (Vargas & Schenberg, 2001). In humans, DPAG 
electrical stimulation produced closely related panic attack 
symptoms such as heart-pounding terror and feelings of 
imminent death accompanied by diffuse face and chest 
pain (Nashold, Wilson, &  Slaughter, 1969).
Previous results from our laboratory indicated that 
rats exposed to contextual cues previously associated 
with electrical footshocks engaged in robust defensive 
freezing behavior and were less likely to display 
running behavior induced by electrical stimulation 
of the DPAG when compared with control animals 
that were not exposed to contextual fear conditioning 
(Magierek et al., 2003). These results corroborate the 
view that anxiety produced an inhibitory effect on 
panic-like behavior. The purpose of this study is to 
further investigate this issue. In the first experiment, 
the Magierek et al. (2003) study was replicated using 
chemical instead of electrical stimulation of the DPAG 
as a model of panic attack. The second experiment also 
investigated the influence of anxiety in the occurrence 
of panic attacks. As in the first experiment, DPAG 
chemical stimulation was used as a model of panic 
attack, whereas pentylenetetrazole (PTZ) instead of 
contextual fear conditioning was employed as the 
anxiety inducing procedure. 
Experiment 1: Effect of contextual fear 
conditioning on the escape responses induced 
by chemical stimulation of the DPAG 
Method
Subjects
Male albino rats from the animal colony of PUC-Rio´s 
Psychology Department were used as subjects. Room 
temperature was controlled (24 ± 1 ºC) and the light-dark 
cycle was maintained on a 12 hr on-off cycle. Animals 
were between 90 to 120 days old at the beginning of the 
experiment and were housed individually in plexiglass 
cages and given free access to food and water throughout 
the experiment. All experimental protocols employed in 
this work are in accordance with the Brazilian Society 
of Neuroscience and Behavior Guidelines for Care and 
Use of Laboratory Animals (SBNeC), which are based 
on the US National Institutes of Health Guide for Care 
and Use of Laboratory Animals (revised in 1996).
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Apparatus
The contextual fear conditioning took place in a 
wooden observational arena measuring 90 X 85 X 90 
cm. The floor of the arena was composed of 55 stainless 
steel rods with a diameter of 1 mm and spaced 1 cm apart 
(center to center). These rods were connected to a shock 
generator and scrambler (AVS, SCR04; São Paulo) with 
an interface that allowed the experimenter to apply 
electrical footshocks. A red light bulb (40 watts) in the 
ceiling of the experimental room and a small camera 
placed above the arena allowed the experimenter to 
observe the animal’s behavior on a monitor located 
outside the experimental room.
Surgery
All animals were implanted with a unilateral guide 
cannula made of stainless steel aimed at the DPAG. 
Under tribromoethanol anesthesia (250 mg/kg, i.p.), 
each animal was fixed in a Kopf stereotaxic frame and 
injected locally with lidocaine (20 mg/ml). The upper 
incisor bar was set at 3.3 mm below the interaural line 
such that the skull was horizontal between bregma and 
lambda. The following coordinates were employed for 
implantation of the guide cannula, with the lambda 
serving as the reference for each plane according 
to the Paxinos and Watson (1986) rat brain atlas: 
anteroposterior (AP) = +2.3 mm; mediolateral (ML) = 
-1.7 mm; and dorsoventral (DV) = -4.5 mm. The guide 
cannula was attached to the skull of the animal with 
acrylic resin and two steel screws. A stylet with a guide 
cannula of the same length was introduced inside the 
guide cannula to prevent obstruction.
Intracerebral Injection
The experiment began 1 week after surgery. NMDA 
microinjection (Sigma, St. Louis, USA) was performed 
using an internal cannula (22 ga, Plastic One) that was 
introduced 0.5 mm below the guide cannula. The injection 
cannula was connected to a 5 µl Hamilton syringe via PE 
tubing and 0.3 µl of NMDA (15.0 µg/µl) or saline was 
microinjected. The displacement of an air bubble inside the 
PE tubing was used to monitor NMDA microinjection.
Procedure
Animals in the first group (conditioning/NMDA) 
were placed in the observational arena for 5 minutes. 
At the end of this period, three unsignaled electrical 
footshocks (1 mA, 1 sec) were delivered with a 20 
second intershock interval. The animals were returned 
to their home cages 1 minute after the last shock. The 
testing session occurred 6 hours after the contextual fear 
conditioning training and lasted 30 minutes. Animals 
were microinjected with NMDA into the DPAG and 
immediately placed in the same arena where the three 
footshocks had been previously administered. Animals 
in the second group (conditioning/saline) underwent 
exactly the same procedure except that saline was 
microinjected into the DPAG before the beginning of the 
testing session instead of NMDA. Animals in the third 
group (no conditioning/NMDA) underwent the same 
procedure as the first group without any footshocks. 
Finally, animals in the fourth group (no conditioning/
saline) did not undergo the contextual fear conditioning 
procedure and saline was microinjected into the DPAG 
before testing. Running and jumping behaviors were 
scored during the test session. Running was defined as 
fast locomotion with elevation of the trunk and tail and 
swinging movements of contralateral limbs (Bittencourt 
et al, 2004). Jumping was scored when the animal 
presented four paws in the air.  
Histology
At the end of the experiment, animals were deeply 
anaesthetized with chloral hydrate and perfused 
intracardially with saline solution (0.9%) followed by 
formalin solution (10%). The cannulas, as well as the 
brains, were removed and placed in a 10% formalin 
solution. Three days later, the brains were frozen and 
50 µm brain sections were cut using a microtome and 
stained with cresyl blue to localize cannula positions.
Data analysis
Previous experiments have shown that saline 
microinjection into the DPAG does not lead to aversive 
responses such as running and jumping (Molchanov 
& Guimarães, 1999). This implies that no variance 
should occur in the groups that were microinjected 
with saline and that the between-group variance should 
differ according to treatment. Therefore, nonparametric 
statistics were used to analyze the present results. The 
Kruskal-Wallis test was used to determine overall 
differences among groups, followed by the Mann-
Whitney test for pairwise comparison.
Results
Histological examination of the brain slices 
indicated that the internal cannula were located 
inside or at the borders of DPAG. Animals with 
cannula outside the DPAG were excluded from 
statistical analysis. The final sizes of each of the four 
groups were as follows: conditioning/NMDA, N = 6; 
conditioning/saline, N = 6; no conditioning/NMDA, 
N = 6; no conditioning/saline, N = 7. 
Table 1 shows the median running and jumping 
frequency as well as running time following NMDA 
or saline microinjection into the DPAG among animals 
with or without contextual fear conditioning. A Kruskal-
Wallis test indicated a significant difference among 
groups in the occurrence of jumping frequency, (H(3) = 
10.77; p < .05). A post hoc analysis performed with the 
Mann Whitney test indicated that the no conditioning/
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NMDA group presented no significant difference in 
jumping behavior when compared to the conditioning/
NMDA group (p > .05) and significantly higher jumping 
behavior when compared to other two groups (ps < 
.05). A Kruskal-Wallis test also indicated a significant 
difference among groups in the occurrence of running 
frequency, (H(3) = 15.0; p < .05). A post hoc analysis 
performed with the Mann Whitney test indicated that the 
no conditioning/NMDA group presented a significantly 
higher running frequency when compared to the other 
three groups (ps < .05 for all comparisons). Finally, a 
Kruskal-Wallis test indicated a significant difference 
among groups in relation to running time (H(3) = 15.0; 
p < .01.). A post hoc analysis performed with the Mann 
Whitney test indicated that the no conditioning/NMDA 
group had a significantly higher different running time 
when compared to the others three groups (ps < .05 for 
all comparisons). 
Experiment 2: Effect of pentylenetetrazol 
on the escape responses induced by chemical 
stimulation of the DPAG 
Methods
Animals and apparatus
This experiment used rats with the same 
characteristics as described in experiment 1, and the 
experiment took place in the same arena.
Procedure 
All the animals were submitted to the same surgical 
procedure described in Experiment 1 for implanting 
the unilateral guide cannula into the DPAG. One week 
after surgery, the first group of animals (PTZ/NMDA) 
received an i.p. injection of PTZ (15 mg/ml; Sigma-
Aldrich, Poland) five minutes before being introduced to 
the observational arena. The PTZ dose employed in this 
study was chosen based on previous work from our group 
(Cruz, Frei, & Graeff, 1994) as well as from reports in 
the literature (Ramos et al., 2008). Immediately before 
being placed into the observational arena, each animal 
received an NMDA (0.3 µl/15.0 µg/µl) microinjection 
into the DPAG. Animals in the second group (Saline/
NMDA) underwent exactly the same procedure as the 
first group with the exception that saline (0.9%) instead 
of PTZ was injected intraperitoneally. As in the first 
experiment, running and jumping behavior were scored 
during a 30 minute test session.  
Results
Histological examination of brain slices indicated 
that internal cannulas were located within the DPAG area. 
Animals with cannulas outside the DPAG were excluded 
from statistical analysis. The final group samples were: 
Saline/NMDA, N = 14; PTZ/NMDA, N = 12.
Figure 1 presents the mean (±SEM) of jumping 
frequency (upper portion), running frequency (middle 
portion) and running time (lower portion). The student’s 
t-test was employed to evaluate statistical differences 
between groups for these three behavioral measurements. 
The analyses indicated a reliable difference in jumping 
frequency (t(24). = 2.8; p < .001), running frequency (t(24) 
= 3.7; p < .001) and running time (t(24) = 4.5; p < .001). 
All behavioral indices indicated that escape responses 
induced by NMDA microinjections into the DPAG were 
lower among animals injected with PTZ when compared 
to control groups that received i.p. injections of saline.   
Discussion
Chemical stimulation of DPAG resulted in well-
defined escape/defensive behaviors such as running and 
jumping. This behavioral outcome has also been reported by 
other studies (Bandler & Carrive, 1988; Behbehani, 1995; 
Krieger & Graeff, 1985). The first experiment indicated 
that contextual fear conditioning was capable of inhibiting 
escape behavior induced by NMDA microinjection into the 
DPAG. These results extend previous findings reported by 
Magierek et al. (2003) and are in agreement with the view 
that anticipatory anxiety (as modeled in this experiment 
Table 1 - Median (minimum - maximum) of running and jumping behaviors in rats treated with DPAG microinjection of 
NMDA (.3 µl of 15.0 µg/µl) or saline among animals exposed (presence) or not exposed (absence) to contextual cues previously 
associated with footshock (contextual fear conditioning). 
Behavioral Output Contextual Fear Conditioning
DPAG Microinjection
Saline NMDA
Jumping frequency Absent 0 (0 - 0) 3.4 (0 - 25)
Present 0 (0 - 0) 0 (0 - 7)
Running frequency Absent 0 (0 - 0) 1.5 (0 - 6)
Present 0 (0 - 0) 0 (0 - 0)
Runing time (sec) Absent 0 (0 - 0) 9.5 (0 - 68)
 Present 0 (0 - 0) 0 (0 - 0)
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by contextual fear conditioning) plays an inhibitory role 
in panic attack genesis (as modeled by NMDA stimulation 
of the DPAG).
Experiment II indicated that intraperitoneal 
PTZ injection was capable of inhibiting the escape 
responses induced by microinjection of NMDA into 
the DPAG. Although these results also corroborate 
the perspective that anxiety inhibits panic attacks, 
they are not in accordance with the report by 
Schenberg et al. (2001) showing that PTZ (50 mg/
kg) facilitated escape responses elicited by NMDA 
microinjection into the DPAG. Differences in the 
PTZ dose between Schenberg et al. (2001) and 
the present study could be responsible for these 
conflicting results. Doses from 10 to 20 mg/kg have 
been shown to be the prototypical anxiogenic doses 
utilized in animal models of anxiety (Ramos et al., 
Figure 1 - Mean (±SEM) jumping frequency (upper portion), 
running frequency (middle portion) and running time (lower 
portion) induced by NMDA (.3 µl at 15.0 µg/µl) microinjections 
into the DPAG among animals intraperitoneally injected with 
saline or PTZ (15 mg/kg).
2008), whereas doses ranging from 40 to 120 mg/
kg produce seizures (Velisek et al., 1992) and have 
been used as an animal model of epilepsy. 
PTZ is a GABAA antagonist. DPAG has been shown 
to contain a significant number of GABAergic interneurons 
that play an important inhibitory role on the regulation 
of defensive behavior (Brandão et al. 1986; DiScala & 
Sandner 1989). For example, DPAG microinjections of 
GABA receptor antagonists or inhibitors of glutamic acid 
decarboxylase, the enzyme responsible for GABA synthesis, 
produced unambiguous active defensive responses such as 
running and jumping (Brandão et al. 1982, 1986; Schmitt 
et al. 1985). Therefore, intraperitoneal injection of high 
doses of PTZ in the Shenberg et al. (2001) study might 
have led to a decrease in GABAA receptor function within 
the DPAG, thus facilitating escape reactions induced by 
stimulation of this area. 
Several lines of evidence have suggested that 
anticipatory anxiety and panic attacks are mediated by 
distinct neural circuitries. Anxiety seems to be associated 
with limbic forebrain structures such as the amygdaloid 
complex, whereas panic attacks are related to more 
primitive hindbrain structures such as the DPAG. Fibers 
originating from the DPAG innervate various forebrain 
regions, including the amygdaloid complex, through 
the medial forebrain bundle (Cameron et at., 1995). 
Therefore, regular hyper-activation of the DPAG could 
lead to the development of PD through this ascending 
projection. On the other hand, activation of forebrain 
areas such as the amygdaloid complex produces several 
autonomic and behavioral reactions associated with 
anxiety through descending projections that reach 
hypothalamic nuclei and mesencephalic structures. 
Descending inhibitory projections might reach the 
DPAG, which could be responsible for the inhibitory 
role of anxiety in the occurrence of panic attacks, and 
this possibility is an important consideration for the 
interpretation of the present results.  
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